Advertisement

Topics

One Drop and MannKind team for inhalable insulin trial

09:24 EDT 9 Aug 2017 | pharmaphorum

Diabetes management platform developer One Drop is to feature in a new trial investigating MannKind’s inhalable insulin, Afrezza. Named the A-ONE study, the trial will couple the use of One Drop’s digital diabetes management platform with the ...

Original Article: One Drop and MannKind team for inhalable insulin trial

NEXT ARTICLE

More From BioPortfolio on "One Drop and MannKind team for inhalable insulin trial"

Quick Search
Advertisement